ID23307A - Polimorf zopolrestat monohidrat - Google Patents

Polimorf zopolrestat monohidrat

Info

Publication number
ID23307A
ID23307A IDP990796A ID990796A ID23307A ID 23307 A ID23307 A ID 23307A ID P990796 A IDP990796 A ID P990796A ID 990796 A ID990796 A ID 990796A ID 23307 A ID23307 A ID 23307A
Authority
ID
Indonesia
Prior art keywords
polyoror
monohidrat
zopolrestat
zopolrestat monohidrat
polyoror zopolrestat
Prior art date
Application number
IDP990796A
Other languages
English (en)
Indonesian (id)
Inventor
John Francis Lambert
Timothy Norris
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ID23307A publication Critical patent/ID23307A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Steroid Compounds (AREA)
IDP990796A 1998-08-21 1999-08-20 Polimorf zopolrestat monohidrat ID23307A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9747498P 1998-08-21 1998-08-21

Publications (1)

Publication Number Publication Date
ID23307A true ID23307A (id) 2000-04-05

Family

ID=22263562

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP990796A ID23307A (id) 1998-08-21 1999-08-20 Polimorf zopolrestat monohidrat

Country Status (31)

Country Link
US (1) US6159976A (ru)
EP (1) EP0982306A3 (ru)
JP (1) JP2000072769A (ru)
KR (1) KR20000017411A (ru)
CN (1) CN1245804A (ru)
AP (1) AP9901662A0 (ru)
AU (1) AU4453299A (ru)
BG (1) BG103674A (ru)
BR (1) BR9903873A (ru)
CA (1) CA2280590A1 (ru)
EA (1) EA199900675A3 (ru)
EE (1) EE9900385A (ru)
GT (1) GT199900137A (ru)
HR (1) HRP990259A2 (ru)
HU (1) HUP9902783A3 (ru)
ID (1) ID23307A (ru)
IL (1) IL131419A0 (ru)
IS (1) IS5155A (ru)
MA (1) MA26678A1 (ru)
NO (1) NO994027L (ru)
NZ (1) NZ337363A (ru)
OA (1) OA11150A (ru)
PA (1) PA8480601A1 (ru)
PE (1) PE20000993A1 (ru)
PL (1) PL335016A1 (ru)
SG (1) SG83147A1 (ru)
TN (1) TNSN99159A1 (ru)
TR (1) TR199901996A2 (ru)
UY (1) UY25668A1 (ru)
YU (1) YU39899A (ru)
ZA (1) ZA995297B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3597650T3 (da) 2010-07-16 2022-11-21 Univ Columbia Aldosereduktasehæmmere og anvendelser deraf
US8916563B2 (en) 2010-07-16 2014-12-23 The Trustees Of Columbia University In The City Of New York Aldose reductase inhibitors and uses thereof
WO2014126885A1 (en) * 2013-02-13 2014-08-21 Mylari Banavara L Water soluble salts of aldose reductase inhibitors for treatment of diabetic complications
EP4316603A3 (en) 2016-06-21 2024-04-17 The Trustees of Columbia University in the City of New York 4-oxo-3,4-dihydrothieno[3,4-d]pyridazine compounds as aldose reductase inhibitors and methods of use thereof
EP4417260A2 (en) 2017-07-28 2024-08-21 Applied Therapeutics, Inc. Compositions and methods for treating galactosemia
KR20220003529A (ko) 2019-04-01 2022-01-10 어플라이드 테라퓨틱스 인크. 알도스 리덕타제의 억제제
AU2020268368A1 (en) 2019-05-07 2022-01-06 Ucl Business Ltd Treatment and detection of inherited neuropathies and associated disorders
EP4125909A1 (en) 2020-03-31 2023-02-08 Applied Therapeutics Inc. Aldose reductase inhibitors for the treatment of acute respiratory distress syndrome, acute lung inflammation/injury, cardiac injury and anti-viral therapy
AU2021264454A1 (en) 2020-05-01 2022-12-08 Applied Therapeutics, Inc. Aldose reductase inhibitors for treating sorbitol dehydrogenase deficiency

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4939140A (en) * 1985-11-07 1990-07-03 Pfizer Inc. Heterocyclic oxophthalazinyl acetic acids
US4748280A (en) * 1985-11-07 1988-05-31 Pfizer Inc. Certain chlorination process for preparing 2-chloro-1,1,1-(C1 -C6)
US4868301A (en) * 1987-06-09 1989-09-19 Pfizer Inc. Processes and intermediates for the preparation of oxophthalazinyl acetic acids having benzothiazole or other heterocyclic side chains
JPH0676391B2 (ja) * 1987-06-09 1994-09-28 フアイザー・インコーポレイテツド ベンゾチアゾール等の複素環側鎖を有するオキソフタラジニル酢酸類の製造方法
US4904782A (en) * 1988-02-29 1990-02-27 Pfizer Inc. Process for the production of phthalazineacetic acid ester derivatives and a novel intermediate
US4954629A (en) * 1989-05-11 1990-09-04 Pfizer Inc. Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof
WO1992003432A1 (en) * 1990-08-28 1992-03-05 Pfizer Inc. 3-(5-trifluoromethylbenzothiazol-2-ylmethyl)-4-oxo-3h-phythalazin-1-ylacetic acid monohydrate
US5391551A (en) * 1993-05-10 1995-02-21 Pfizer Inc. Method of lowering blood lipid levels
IL120264A0 (en) * 1996-02-29 1997-06-10 Pfizer Method of reducing tissue damage associated with non-cardiac ischemia

Also Published As

Publication number Publication date
HUP9902783A3 (en) 2001-01-29
MA26678A1 (fr) 2004-12-20
HU9902783D0 (en) 1999-10-28
AP9901662A0 (en) 1999-09-30
EE9900385A (et) 2000-04-17
AU4453299A (en) 2000-03-09
CN1245804A (zh) 2000-03-01
NO994027D0 (no) 1999-08-20
TR199901996A2 (xx) 2000-03-21
US6159976A (en) 2000-12-12
GT199900137A (es) 2001-02-09
HUP9902783A2 (hu) 2000-12-28
IL131419A0 (en) 2001-01-28
PL335016A1 (en) 2000-02-28
EA199900675A2 (ru) 2000-02-28
NO994027L (no) 2000-02-22
YU39899A (sh) 2002-12-10
EA199900675A3 (ru) 2000-06-26
BR9903873A (pt) 2000-09-19
SG83147A1 (en) 2001-09-18
CA2280590A1 (en) 2000-02-21
NZ337363A (en) 2001-01-26
EP0982306A3 (en) 2000-07-05
TNSN99159A1 (fr) 2005-11-10
ZA995297B (en) 2001-02-19
HRP990259A2 (en) 2000-06-30
IS5155A (is) 2000-02-22
JP2000072769A (ja) 2000-03-07
PE20000993A1 (es) 2000-10-04
OA11150A (en) 2003-04-16
UY25668A1 (es) 2001-08-27
EP0982306A2 (en) 2000-03-01
PA8480601A1 (es) 2000-09-29
BG103674A (en) 2000-03-31
KR20000017411A (ko) 2000-03-25

Similar Documents

Publication Publication Date Title
ID29066A (id) Turunan fenilglisina
ID27423A (id) Turunan kuinolin
DE59914158D1 (de) Metallocenmonohalogenide
ATE341990T1 (de) Sigmidoskop
DE69808145D1 (de) Tintenbehälternachfüllsystem
DE59901560D1 (de) Retrograder tibianagel
DE59902874D1 (de) Buchsenkontakt
ID23234A (id) Turunan-turunan benzosulfona
ID27484A (id) Turunan adenosina
DE59907306D1 (de) Fadenchangierung
ID27547A (id) Turunan kuinolin
DE59906931D1 (de) Exzenterzahnradgetriebe
DE59911683D1 (de) Fahrzeugschliessanlage
ID24221A (id) Tempat patrum
DE59908968D1 (de) Benzoylpyridazine
DE59903966D1 (de) Exzenterzahnradgetriebe
DE59908769D1 (de) N-arylsulfonyl-aminosäure-omega-amide
DE59903106D1 (de) Tripode-gleichlaufdrehgelenk
ID23307A (id) Polimorf zopolrestat monohidrat
DE59908057D1 (de) Underdruckhandhabungseinrichung
DE69809804D1 (de) Notlaufgeländereifen
DE59901046D1 (de) Methylcyclotetradec-5-en-1-one
FI980187A0 (fi) Vattenturbinsystem
DE59807217D1 (de) Nadellager
ID28356A (id) Turunam tiazola